AzTrials
AzTrials

Intra-articular FracturesNCT02446470

Sinus Tarsi Versus Extensile Lateral Approach for Calcaneus Fractures

A study testing Sinus Tarsi approach and Extensile Lateral approach in people with Intra-articular Fractures, run by University of Tennessee at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a prospective, randomized controlled trial comparing the sinus tarsi approach to the extensile lateral approach for surgical fixation of calcaneus fractures. It is hypothesized that open reduction and internal fixation of intra-articular calcaneus fractures using a sinus tarsi approach will provide… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intra-articular Fractures
What is being tested?
Sinus Tarsi approach and Extensile Lateral approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
May 2015to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Skeletally mature patients ≥ 18 years of age
  • Closed intra-articular calcaneus fractures
  • Undergoing surgical fixation (CPT code 28415)
  • Ability to understand and agree to informed consent

Who cannot join

  • Patients < 18 years of age
  • Open fractures
  • Dislocations that require open reduction
  • Previous calcaneus abnormality or injury
  • Unable to understand or agree to informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Erlanger Health System

    Chattanooga, Tennessee, 37403

Other trials in United States

About this study

Official title: Sinus Tarsi Versus Extensile Lateral Approach for Open Reduction Internal Fixation of Intra-articular Calcaneus Fractures

This study is a prospective, randomized controlled trial comparing the sinus tarsi approach to the extensile lateral approach for surgical fixation of calcaneus fractures.

It is hypothesized that open reduction and internal fixation of intra-articular calcaneus fractures using a sinus tarsi approach will provide equivalent fracture reduction and stable fixation with significantly decreased wound complication rates in comparison to an extensile lateral approach.

Being tested
Sinus Tarsi approach, Extensile Lateral approach
Keywords
calcaneus, fracture fixation, internal
Medical subject headings
Intra-Articular Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sinus Tarsi approachProcedure or surgery

    A straight incision is made on the lateral side of the foot from the tip of the fibula to the base of the fourth metatarsal which centers the incision over the sinus tarsi. Then careful dissection is made through the subcutaneous tissues to prevent damage to the sural nerve, peroneal tendons, and extensor digitorum brevis (EDB). The origin of EDB is identified and the muscle is released distal enough to fully visualize the fracture and articular surface of the calcaneus. Following exposure of the fracture and articular surface of the calcaneus, open reduction and restoration of the articular surface of the calcaneus will be achieved followed by stable fracture fixation with plates and screws as dictated by the specific fracture pattern.

  • Extensile Lateral approachProcedure or surgery

    An L-shaped incision overlying the lateral wall of the calcaneus will be made, followed by sharp dissection of soft tissues in line with the skin incision down to the periosteum. Effort will be made to identify and protect the sural nerve, as it commonly crosses the surgical field with this approach. The soft tissue flap is retracted as a single unit as subperiosteal dissection is performed. Following exposure of the lateral wall of the calcaneus, open reduction and restoration of the articular surface of the calcaneus will be achieved followed by stable fracture fixation with plates and screws as dictated by the specific fracture pattern.

Study groups in NCT02446470
Study groupRoleWhat they receive
Sinus Tarsi approachExperimentalThe Sinus Tarsi approach is the surgical approach for the incision.
Receives: Procedure: Sinus Tarsi approach
Extensile Lateral approachActive comparatorThe Extensile Lateral approach is the surgical approach for the incision.
Receives: Procedure: Extensile Lateral approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wound complication rate

    There is an expected wound complication rate of up to 30% with this type of fracture. The difference in wound complication rate between the two surgical approaches will be the primary outcome measure. Wound complications will be defined by the presence of superficial or deep infections, skin edge necrosis, and soft tissue sloughing.

    Measured: approximately one year

Secondary outcomes (9)
  1. Fracture healing

    On radiographic and clinical exam

    Measured: approximately one year

  2. Rate of sural nerve injury

    Measured: approximately one year

  3. Rate of peroneal tendon injury

    Measured: approximately one year

  4. Change in operative time

    Measured: one day

  5. Rate of secondary surgery

    Measured: approximately one year

  6. Visual Analog Scale

    Pain Score

    Measured: approximately one year

  7. American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale

    Functional Outcome Score

    Measured: approximately one year

  8. Foot Function Index

    Functional Outcome Score

    Measured: approximately one year

  9. Short-Form 36 (SF-36) Health Survey

    Functional Outcome Score

    Measured: approximately one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2015 (estimated)
  2. Study startMay 2015
  3. Primary completionDec 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02446470
Sponsor's protocol ID
15-026
Status last verified
Nov 2018
First submitted
30 Apr 2015
Last updated
29 Nov 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sinus Tarsi approach and Extensile Lateral approach in people with Intra-articular Fractures, run by University of Tennessee at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wound complication rate (time frame: approximately one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in